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Summary
Background: Since intracranial electrode implantation has limited spatial sampling and carries
signiﬁcant risk, placement has to be effective and efﬁcient. Structural and functional imag-
ing of several different modalities contributes to localising the seizure onset zone (SoZ) and
eloquent cortex. There is a need to summarise and present this information throughout the
pre/intra/post-surgical course.
Methods: We developed and implemented a multimodal 3D neuroimaging (M3N) pipeline to
guide implantation of intracranial EEG (icEEG) electrodes. We report the implementation of
the pipeline for operative planning and a description of its use in clinical decision-making.
Results: The results of intraoperative application of the M3N pipeline demonstrated clinical
beneﬁts in all 15 implantation surgeries assessed. The M3N software was used to simulate
placement of intracranial electrodes in 2 cases. The key beneﬁts of using the M3N pipeline are
illustrated in 3 representative case reports.
 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.
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Conclusion: We have demonstrated feasibility of the developed intraoperative M3N pipeline
which serves as a prototype for clinical implementation. Further validity studies with larger
sample groups are required to determine the utility of M3N in routine surgical practice
Crown Copyright © 2013 Published by Elsevier B.V. All rights reserved.
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• The anatomical T1-weighted image obtained previously
and which deﬁnes the spatial basis for preoperative imagentroduction
ultimodal 3D neuroimaging (M3N) applied to navigation
uring neurosurgical operations is a technique which utilises
re- and intraoperative display of multimodal data in the
euronavigation system. The beneﬁts of M3N have been
ecognised during resection of brain tumours (González-
arder et al., 2010; Nimsky et al., 2011; Spena et al., 2010;
harin and Golby, 2007). There are few reports of intraop-
rative use of M3N for surgical treatment of refractory focal
pilepsy (Holowka et al., 2004; Murphy et al., 2004; Wellmer
t al., 2010).
The area of brain that needs to be removed to achieve
eizure freedom, often referred to as the epileptogenic
one (EZ), may not be associated with a clear structural
bnormality and may impinge on eloquent cortex, dam-
ge to which would cause a new deﬁcit (Duncan, 2010). In
hese cases, it may be necessary to place subdural and/or
ntracerebral depth electrodes to deﬁne the site of seizure
nset (SoZ), that must be removed to give the optimal
hance of seizure freedom, and its relation to eloquent
ortex (Duncan, 2011). Spatial sampling from intracranial
lectrodes is limited and placement carries signiﬁcant risk
Tanriverdi et al., 2009). Therefore, electrode placements
eed to be of optimal effectiveness and efﬁciency.
The visualisation of multimodality neuroimaging data in
dimensions offers increased sophistication and accuracy
or electrode placement. Structural and functional imag-
ng of several different modalities allows inferences to
e drawn on the location of the SoZ, and also eloquent
reas and critical cerebral structures. This data may include
tructural MRI, tractography, vascular imaging, functional
RI of eloquent functions and epileptic activity, cere-
ral perfusion (SPECT — Single-Photon Emission Computed
omography), glucose metabolism (FDG-PET — Fluorodeoxy-
-Glucose Positron Tomography), magnetic source imaging
MSI) and electrical source imaging (ESI). Traditionally, such
atasets have been viewed individually, in 2-dimensional
lices. Advances in visualisation software and computing
ardware have led to the potential ability to place diverse
atasets in the same individual patient brain space and to
iew such data in 2- and 3-dimensions, with interactive
isualisation of the brain surface and deep structures.
We report the feasibility of intraoperative use of M3N
o guide implantation of icEEG electrodes, describe the
ethodology with our instrumental platform and illustrate
he implementation of the platform in 15 individuals with
rug-resistant focal epilepsies.
ethods. Implementation of M3N for operative
lanning
he M3N pipeline is used to support clinical decision making
t all stages including the discussion of treatment strat-gy, planning and performing icEEG electrode implantation,
cEEG analysis, resective surgery and analysis of postop-
rative outcome. This pipeline would be widely applicable
cross sites, and can import data from a wide range of imag-
ng protocols.
The detailed pipeline of M3N is described in Supplement
and illustrated in Fig. 1. The typical parameters (matrix
ize and voxel size) of the images utilised in our implemen-
ation of M3N are listed in the Table 1. These are useful for
pproximate estimation of the required computer memory
nd processing power.
The M3N pipeline requires image integration software.
he key requirements to this software are: (a) variety of
mage processing tools to support typical tasks outlined in
his section and Supplement 2; (b) intuitive and efﬁcient way
f displaying and manipulating 3D imaging information; (c)
bility to rapidly combine basic image processing tools into
orkﬂows for easy and quick application. Amira 5 software
Visualization Sciences Group, USA; www.vsg3d.com) fulﬁls
hese criteria and was used to carry out all image integration
rocessing.
Intraoperative use of M3N begins with previously fused
ultimodal image data (see stage 3 on the left hand side
iagram on the Fig. 1). This data includes some of the land-
arks useful for identiﬁcation of SoZ: abnormal tissue as
egmented from diagnostic T1 and T2 MR images; cortex
enerating interictal epileptic activity as indicated on 3D
apping of MEG, EEG and EEG-fMRI data; cortex showing
ncreased metabolism during seizures as shown by SPECT. In
ddition it is crucial to visualise and present critical struc-
ures such as cortico-spinal tract and optic radiation that
re demonstrated using DTI tractography, arteries and veins
nd eloquent cortex (e.g. motor and language functions
ocalised using fMRI).
The algorithm for the intraoperative use of M3N com-
rises the following steps (see stages 3.1—3.4 on Fig. 1):
The anatomical MR image (T1-weighted with gadolinium
contrast) with skin ﬁducials on the scalp and used for nav-
igation (navMRI) is obtained immediately prior to surgery.
The ﬁducials used for coregistration of the image with
the patient’s head are clearly visible on the image. This
image represents the basis to which binary spatial labels
representing all surgically relevant 3D models are fused.
This image is not spatially transformed during further
processing, to facilitate seemless coregistration of the
images that contain all 3D models with the navMRI on the
neuronavigation system.fusion is coregistered with the navMRI dataset using a
rigid body transformation (rotation around and transla-
tion along three axes). The resulting transformation is
applied to all other imaging modalities, providing useful
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Fig. 1 Workﬂow of M3N for presurgical evaluation of epilepsy patients with focus on the details of the data integration stage for
guidance of implantation.
Table 1 The typical geometric parameters of the typical images utilised in M3N.
Image type Matrix size Voxel size (mm)
Navigation image (with MR-contrast ﬁducials): gadolinium enhanced
T1 MPR
512× 512× 144 0.5× 0.5× 1.5
Diagnostic anatomical images T1 FSPGR 256× 256× 166 0.94× 0.94× 1.1
T2 FLAIR 256× 160× 32 0.94× 1.5× 3.5
Vascular images MRV Time of Flight 256× 256× 93 0.94× 0.94× 2
3D Phase Contrast MR 256× 256× 160 0.85× 0.85× 1
Functional imaging (fMRI): T2* GE planar (acquired 96× 96 inplane) 128× 128× 58 1.87× 1.87× 2.5
White matter ﬁbre tracking - Diffusion Tensor Imaging (DTI): T2 SE
planar (acquired 96× 96 inplane)
128× 128× 60 1.87× 1.87× 2.4
Ictal perfusion: SPECT 128× 128× 49 3.9× 3.9× 3.9
Metabolism: FDG PET 128× 128× 47 1.95× 1.95× 3.3
•Localisation of icEEG electrodes: CT
landmarks for inferring the spatial characterisation of the
SoZ and consequently useful intraoperatively.
• The images of landmarks are converted into a set of
homogenous masks for fusion with the navMR image.
Consecutive masks are assigned different intensities to
facilitate differentiation between them in the resulting
image.512× 512× 172 0.4× 0.4× 1
Planning depth electrode implantation. The placement of
depth electrodes can be simulated by adding 3D models
representing the size and location of both depth and sub-
dural electrodes (Figs. 2 and 3). The display of depth
electrodes facilitates the avoidance of pial boundaries
and major blood vessels, and allows for targeting of struc-
tural and functional data.
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Fig. 2 3D models simulating intracranial depth electrodes.
Patient 13.
Depth electrode entry points chosen at the crown of gyri and
avoiding pial boundaries. Entry points of the 3D models of the
depth electrodes are seen in the middle of the white circles. Red
— lesion; green cluster — hand motor area labelled using fMRI;
cyan — cortical veins. (For interpretation of the references to
c
v
•
Fig. 3 3D model simulating intracranial grid electrode.
Patient 15.
3D model of the grid electrode (the transparent square surface
over Lt temporal lobe) before (a) and after (b) placement of
the intracranial electrodes — individual yellow contacts on (c).
Red — lesion; cyan — cortical veins. (For interpretation of the
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The multimodal masks are fused into the navMRI image
which becomes the image-container of the 3D models
(Figs. 4—6). Note, in cases when it is important to appre-
ciate two or more overlapping areas, the area of overlap
can be encoded as an extra mask. The intensity encod-
ing this additional mask has to be between the intensities
f
a
d
ig. 4 Use of M3N during implantation surgery of Patient 2 (left la
a) pre-implantation; (b) during implantation. The dark blue pointer o
arge cortical vein; (c) post-implantation; (d,e) post-resection with
hand motor areas mapped using fMRI; magenta — ictal hyperperfu
sing fMRI; brown (on a,c; lt precentral gyrus) — spike-related inc
eins; blue (e) — corticospinal tract. (For interpretation of the refe
he web version of this article.)eferences to color in this ﬁgure legend, the reader is referred
o the web version of this article.)
encoding the two overlapping areas. This approach allows
complete representation of overlapping areas.
The resulting 3D image, the image-container of land-
arks is exported in DICOM format, recorded on a CD and
ransferred onto the Stealth Station (MedTronic Inc). The
mage-container is co-registered with the navigation T1 MR
mage and the 3D models are re-created using neuronaviga-
ion software.unction—transport of the 3D models into the neuron-
vigation system in the correct anatomical space. The
iagnostic navigation images required during the surgery
teral 3D views).
n (b) shows Stealth navigation probe when it was placed on the
highlighted removed cortex. Colour codes: red — lesion; green
sion from SPECT; orange — expressive language areas mapped
rease of BOLD signal mapped using EEG-fMRI; cyan — surface
rences to color in this ﬁgure legend, the reader is referred to
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are uploaded into the neuronavigation station following
procedures recommended by the manufacturer. The time
consuming process of preparing the image-container is a
necessary step as the neuronavigation systems use internal
data formats to store complex datasets including 3D models
and implantation plans. The advantage of this approach is
that the resulting image-container can be utilised by any
neuronavigation system which exports DICOM images and
provides tools for manual segmentation of 3D labels into 3D
surface models.
Among the beneﬁts of the pipeline is ability to apply it to
any data set. This ﬂexibility means that the pipeline is not
limited to the modalities reported in the Results section, but
can incorporate new imaging data with clinical potential.
Amira software is not CE marked or FDA approved for clin-
ical use. In order to avoid registration errors, the results of
coregistration were reviewed and conﬁrmed as adequate to
the surgical procedure by at least two experts in neuroimag-
ing.
All visualisations, including the tool OrthoView showing
orthogonal projections, in Amira are implemented in 3D
space. This allows unequivocal identiﬁcation of right/left.
Our experience shows that Amira is consistently correct
in visualising DICOM and Nifti images (tested on over 400
images from seven MR, PET/SPECT, CT scanners). However,
the user should be cautious when interpreting laterality of
any images imported in Analyze format as these are less reli-
able in identiﬁcation of laterality. The tools supporting 2D
image viewing in the form of 3 projections are also available
as secondary option.
The beneﬁts of intraoperative use of M3N were reported
by operating neurosurgeons by comparing clinical decision-
making before and after the display of M3N results, and by
summarising use at the end of each case. However, the focus
of this report is to describe the feasibility of implementing
the intraoperative M3N pipeline.
Results
The intraoperative M3N pipeline was implemented for use
during implantation of icEEG electrodes at the National
Hospital for Neurology and Neurosurgery (Queen Square,
London, UK). M3N was available on the neuronavigation sys-
tem for 15 consecutive implantation surgeries (Supplement
1). The simulation of placement of the depth electrodes was
performed in the two most recent cases.
The research protocol for this study was approved (reg-
istration number 12/LO/0377) by Ethics Committee of the
NHNN. Informed consent was obtained to acquire the imag-
ing data. The beneﬁts from the intraoperative use of M3N
were noted by the two operating neurosurgeons (AWM, AM)
for every surgery (Supplementary material 1).The following three representative case reports illustrate
the beneﬁts of utilisation of M3N including a case in which
the depth electrodes were pre-operatively simulated as 3D
models and these data were used intraoperatively.
Case 2. grid and depth electrodes.
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A 30-year old man presented with refractory left frontal
obe epilepsy from the age of 12 years, with most frequent
eizures characterised by head and eyes version to the right
nd speech arrest. MRI showed a small area of focal cor-
ical dysplasia (FCD) in the bottom of a sulcus within the
eft superior frontal gyrus. SPECT showed increased ictal
lood ﬂow around the area of FCD. Motor hand and language
MRI showed the proximity of these eloquent functions. Trac-
ography demonstrated the corticospinal tract (CST). MR
enography demonstrated the cortical surface veins and
heir relation to the structural lesion, gyral anatomy and
loquent cortex (Supplement 1, Fig. 4). The models were
seful for planning the craniotomy and for identifying the
entral sulcus and the lesion. The set of 3D models was avail-
ble intraoperatively on the neuronavigation system during
he implantation. The operating neurosurgeon conﬁrmed
natomical accuracy of the models using cortical veins as
andmarks (Fig. 4b). The 3D model of cortical veins offered
guide to brain shift and thus facilitated gross correction
hen placing depth electrodes.
The seizure onset zone identiﬁed with intracranial EEG,
reas of cortex involved in rapid propagation of ictal activity
nd the dysplastic lesion were removed (see post-resection
mage fusion on Fig. 4d,e) preserving CST and hand motor
rea. The patient had, as predicted, a minor expressive
peech deﬁcit which improved within 3 months. The patient
as remained seizure free 15 months following surgery.
M3N led to accurate placement of intracranial electrodes
or the purposes of recording seizures and mapping eloquent
unction and was helpful for guiding lesional resection in a
ighly eloquent area.
ase 5. grid electrodes.
A 28-year old woman presented with refractory frontal
obe epilepsy diagnosed at age 10 years. The seizure semi-
logy characterised by tonic and bilateral asymmetric tonic
eizures suggested right frontal lobe onset with involvement
f the supplementary motor area (SMA). No abnormalities
ere found on structural MRI. Ictal SPECT showed hyperper-
usion in the right superior frontal gyrus, in the vicinity of
he SMA (Fig. 5) (Supplement 1).
The 3D models showing major cortical veins, area of
ctal hyperperfusion, left hand motor area were available
n the neuronavigation system during implantation surgery.
he location of the ictal hyperperfusion and the 3D model
f cortical veins were used as landmarks to place small 4× 4
rid electrodes on the medial aspect of the superior frontal
yrus (Fig. 4e) and to locate the central sulcus. The brain
hift was estimated as relatively minor given the size of the
raniotomy.
The SoZ was conﬁrmed by the icEEG and was removed
Fig. 5d,e,f) preserving the CST (Fig. 5f) and motor cor-
ex. As expected following removal of the SMA, there
as mild left hemiparesis affecting mainly the left upper
xtremity for 2 weeks which then resolved completely.
istological analysis showed FCD type IIb. The patient dis-
ontinued all medication 4 months post-operatively. Twelve
onths following the surgery the patient remains seizure
ree.
M3N demonstrated concordance between ictal hyperper-
usion and icEEG ﬁndings in a case of non-lesional epilepsy
96 R. Rodionov et al.
Fig. 5 Use of M3N during implantation surgery of Patient 5.
(a) pre-implantation; (b) post-implantation; (c) during implantation. The dark blue pointer on (c) shows Stealth navigation probe
when it was placed on the surface vein; (d,e,f) post-resection with highlighted removed cortex. Colour codes: green — hand motor
area mapped using fMRI; magenta — area of hypometabolism according to ictal SPECT; cyan — surface veins; dark blue (f) — cortico-
spinal tract. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
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nd guided the resection. The visualisation of the left hand
otor area and CST allowed this resection to be performed
afely.
ase 13. depth electrodes.
A 42-year old woman presented with refractory epilepsy.
he initially developed epilepsy aged 9 years, and under-
ent a right anterior temporal lobe resection aged 11. This
esulted in a change of seizure semiology, with the new
eizures characterised by a left leg somatosensory aura,
ollowed by left arm tonic posturing and secondary generali-
ation. The implantation strategy (Supplement 1) was based
n seizure semiology, scalp EEG and the ischaemic lesion vis-
ble on MRI in the precuneus and medial posterior temporal
e
m
uobe. fMRI demonstrated primary sensory and motor cortex
nd tractography deﬁned the optic radiation (Fig. 6).
The location of the depth electrodes was planned preop-
ratively using the M3N pipeline, enabling precise electrode
ositioning to deﬁne the seizure onset zone and primary
omatosensory cortex, and to minimise the risk of damag-
ng large surface cortical veins (Fig. 6). Post implantation
maging showed that the preoperative electrode placement
sing the M3N pipeline was accurately used in practice.
The plan and3D models made preoperatively, were
ploaded to the neuronavigation system, and used in the
perating room to inform the insertion of the intracranial
lectrodes.
The seizure onset zone was deﬁned in the posterior
edial right temporal lobe and resection has been sched-
led.
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Fig. 6 Use of M3N for implantation of depth electrodes in Patient 13.
(a,b) pre-implantation; (c,d,e,f) post-implantation. Only right hemisphere is shown. Colour codes: red — lesion; light green —
preoperatively simulated electrodes; dark green — hand motor area mapped using fMRI; cyan — surface veins; dark blue — optic
radiation; yellow — individual contacts of implanted electrodes on d,e,f. (a,d) — right lateral 3D views; (b) — left posterior-lateral
view; (e) — medial view; (f) — posterior superior view of the right hemisphere. (c) — skull showing holes used to perform the
implantation (segmented from CT image). (e,f) — electrodes modelled preoperatively using M3N (Amira) compared with placed
electrodes. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
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Automated cortex segmentation was complicated in the
area of previous temporal lobe resection which resulted in
masking out small amount of tissue (Fig. 6 d,f). For this rea-
son the cortical anatomy was estimated using the navigation
T1 image.
M3N was useful for demonstrating the proximity of the
lesion to eloquent brain, and in creating the planned trajec-
tories for electrode implantation with avoidance of vascular
injury.
Discussion
The application of the intraoperative M3N pipeline has
shown that this approach is feasible and has potential util-
ity for guiding the insertion of intracranial EEG electrodes
and the resection of an epileptic focus. Our experience
demonstrates that the M3N pipeline can be implemented
into standard clinical practice in a busy epilepsy surgery
centre.We are not aware of any reports on the system-
atic use of M3N for all epilepsy surgery implantation
cases, incorporating PET, SPECT, MEG, fMRI and tractogra-
phy.
t
T
r
lThere are a few reports of application of intraoperative
ultimodal imaging aiming to guide electrode implanta-
ion (Cohen et al., 2010; Daga et al., 2012; Stadie et al.,
008; Wellmer et al., 2010). However, present experience is
imited to evaluation of effect of preoperative (Cohen et al.,
010; Stadie et al., 2008) or intraoperative (Daga et al.,
012; Wellmer et al., 2010) use of individual modalities. In
eneral, these reports fall into two groups: techniques to
mprove the yield of identifying the epileptogenic zone, and
echniques to identify regions of interest to avoid surgical
omplications.
The use of functional imaging, including FDG-PET, T2
luid Attenuated Inversion Recovery (FLAIR) MRI, ictal
PECT, has been reported in difﬁcult, non lesional cases to
dentify previously occult pathology (Rastogi et al., 2008).
he export of these data to neuronavigation systems places
t in an anatomical framework, and allows the surgeon to
ccurately locate these regions of interest. A recent report
escribes a novel MRI processing technique, which can iden-
ify areas of FCD (Wellmer et al., 2010). These data can be
ransferred to neuronavigation systems, for use in theatre.
here are reports of the use of tractography to guide ante-
ior temporal lobe resections, avoiding damage to Meyer’s
oop (Daga et al., 2012). The integration of vascular imag-
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ng with structural imaging to guide electrode placement is a
ell established technique, ﬁrst described by Talairach and
mployed in stereotactic EEG for over 30 years (Talairach
nd Szikla, 1980).
The key feature of the intraoperative M3N pipeline is
he routine display of all available and relevant structural
nd functional neuroimaging data to aid informed decision-
aking with necessary precision. The particularly useful
spects are:
The coregistration and simultaneous display of multiple
datasets, including T1, T2-weighted and FLAIR MRI acqui-
sitions with lesions highlighted.
The inclusion of derived structural data, particularly crit-
ical white matter tracts, such as cortico-spinal tract and
optic radiation, deﬁned with probabilistic tractography.
Delineation of major cortical veins, obtained with MR
venography.
The display of eloquent motor, sensory, language and
visual cortex, identiﬁed with fMRI.
The addition of other key functional data that infer the
location of the epileptic focus: hypometabolism identiﬁed
with FDG-PET, ictal hyperperfusion identiﬁed with SPECT;
fMRI of interictal epileptic activity obtained with EEG-f
MRI; electrical and magnetic source imaging.
The simulation of depth and subdural electrodes as 3D
objects.
The utilisation of the standardised colour scheme for dis-
play of 3D models.
The following features speciﬁc to planning implantation
ontribute to useful functionality of our pipeline:
. The simulation of depth electrodes as 3D objects allows
optimal selection of target sites and visualisation of the
intracerebral course of the electrode. This is done out-
side the neuronavigation system, allowing greater access
and close consultation with neurologists and neurophys-
iologists. The 3D models of the intracranial electrodes
may then be uploaded on the Stealth workstation to
guide the actual electrode insertion.
. Subdural grid electrodes may be simulated (Fig. 3b,c)
and placed on the rendered surface of the brain, facil-
itating the placement of the subdural grid, to minimise
edges of the grid overlaying major surface veins, and to
ensure good coverage of the presumed epileptic focus
and nearby eloquent cortex, so that functional mapping
may be carried out effectively. Additionally, this is valu-
able for assisting the planning of the craniotomy.
A further potential beneﬁt of the pipeline, noted dur-
ng the course of its implementation in clinical practice,
s its enhancement of communication and decision-making
etween different specialists (neurologists, neurophysiol-
gists, neurosurgeons and neuroradiologists) involved in
atient care.
Current software for M3N applied to neurosurgery fall
nto three categories:
. Basic planning on commercially available neuronavi-
gation systems (Medtronic Stealth Cranial, Medtronic
l
s
t
aR. Rodionov et al.
Inc, USA; BrainLab Cranial Navigation, Brainlab AG,
Germany);
. Specialised planning software as adjunct to neuronaviga-
tion software (StealthViz, Medtronic Inc; iPlan, Brainlab
AG)
. Stand-alone specialised planning software packages
(BioImageSuite, Yale University, USA; 3D Slicer, Brigham
and Women Hospital, USA; Analyze, Mayo Clinic, USA).
Commercially available neuronavigation systems allow
he import of dedicated navigation data sets from MRI and
T, followed by automated coregistration. Thus it is possible
o merge T1 and T2 weighed MRI with CT. It is not possible to
mport other structural or functional data. There is a basic
unctionality for building simple 3D model sets according
o thresholding, but there is very limited functionality with
egards to data processing and analysis, visualisation and
resentation.
Commercially available planning software packages, such
s StealthViz, have advanced functionality, with coregistra-
ion of a wide range of data sets and mature segmentation
ools. However, it is not possible to perform surgical planning
ith his software.
The most versatile systems are the stand-alone spe-
ialised multifunctional software packages (e.g. BioImage-
uite, 3D Slicer, Analyze) that are developed outside of
ndustry. These are used in a range of disciplines in basic
nd clinical science. The major advantage of these pack-
ges is that they are not dedicated to solving speciﬁc
ell-deﬁned problems. This ‘non-specialisation’ means that
here is added ﬂexibility in the processing, manipulation and
isplay of data sets, and an added range of tools to choose
rom.
Our choice of software platform for M3N was Amira. This
oftware combines ﬂexibility, simplicity of use, variety of
unctions and interactive image display, and allowed the
imulation of implanted hardware for epilepsy surgery plan-
ing. The ﬂexibility of Amira can be illustrated by its ability
o implement simulation of electrode placement. In this way
mira-based instrumental part of M3N supports all image
rocessing tasks arising in the process of surgical treatment
f epilepsy.
We anticipate three barriers to the widespread adoption
f M3N in clinical practice:
organisational infrastructure;
accuracy;
validity.
Firstly, M3N is a complex addition to a clinical path-
ay, which requires considerable changes in organisational
nfrastructure. The ﬁrst requirement is the availability of the
ange of imaging modalities, along with the time and exper-
ise to perform relevant pre-processing of data. The second
equirement is the availability of expert data integration
nd validation, which requires specialist training and can be
ostly in terms of man hours. Currently, a complete data set
or a patient requires 8—12 hours work with the use of at
east 4GB of RAM. The third requirement is a common con-
ensus by the entire multi-disciplinary team to engage with
he programme, accepting that adoption is accompanied by
learning curve in how best to present and use the data.
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Once the Amira-based instrumental part of M3N is imple-
mented into the clinical context of an epilepsy centre it can
be successfully operated either by a radiology technician or
a clinical scientist.
Secondly, the accuracy of M3N is complex and varied.
The old adage by Aristotle, ‘‘You get out what you put in’’
is especially pertinent to M3N, where some data sets will
be reliable and reproducible such as structural MRI, and
other sets will have considerable inter-user variability such
as tractography (Heiervang et al., 2006). Some data sets
are further limited by their own biophysical principles; for
example, blood oxygen level dependent signal in fMRI is an
indirect measure of neuronal activity, and tractography is
a presumption of white matter connectivity. Interpretation
of these within an integrated data set requires differential
levels of caution and conﬁdence.
Integration and presentation of multimodality imaging
is a step-wise process of spatial coregistration, and each
step carries a margin of error. For this reason it is essen-
tial that coregistration is checked manually, and that errors
in anatomical localisation such as laterality, are checked at
each stage. We aim for a coregistration accuracy of 2—5mm,
where lower accuracy is similar to the spatial resolution of
fMRI, tractography, PET and SPECT. Targeting deep central
structures requires anatomical precision of 1—2mm, and for
this high resolution anatomical MRI is used. We did not aim
to perform quantitative analysis of coregistration accuracy
provided by Amira and the result of every coregistration was
evaluated visually.
For M3N to be available to the neurosurgeon in theatre,
the data sets are exported to a neuronavigation system, and
a further registration takes place between the 3D model and
the patients head. This adds a further margin of error, which
is dictated by the neuronavigation software and quality of
registration. The accuracy of this spatial registration fur-
ther deteriorates as the surgical procedure takes place, due
to brain shift. This is the intraoperative displacement and
distortion of the brain that inevitably occurs during opera-
tions, as a result of CSF loss, gravity, brain swelling and brain
resection. The aggregation of these margins of error has to
be considered as the neurologist or neurosurgeon integrates
this additional tool into clinical practice.
Finally, a further barrier to the widespread use of M3N is
the absence of evidence that this is a clinically useful tool
in terms of improved outcome. In our experience the tool
has been helpful in the planning and performing of surgery,
although we acknowledge the possibility of observer bias.
Epilepsy surgery does not easily lend itself to randomised
controlled trials, and we would suggest uptake critical eval-
uation and reporting of these techniques and comparison
with currently treated cohorts.
Conclusion and further developments
We routinely use fully integrated multimodal images in
the presurgical evaluation and surgical planning of epilepsy
cases. Having shown the feasibility of the intraoperative M3N
approach and its application to icEEG placement, we are
now establishing a clinical trial to demonstrate utility and
cost-effectiveness.
Dof intracranial EEG electrodes 99
In addition, we are developing a new, semi-automated
oftware programme to replace the Amira-based prototype,
hat will be quicker, easier to use and more practical in the
nvironment of a busy epilepsy surgery centre. Despite the
easibility of routine intraoperative M3N as shown in this
aper, the availability of dedicated software platform for
3N would facilitate more widespread uptake.
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